Analysts downgrade SBI Card as poor asset quality, rising costs bite in Q3

https://www.business-standard.com/markets/news/analysts-downgrade-sbi-card-as-poor-asset-quality-rising-costs-bite-in-q3-124012900255_1.html Clipped from: https://www.business-standard.com/markets/news/analysts-downgrade-sbi-card-as-poor-asset-quality-rising-costs-bite-in-q3-124012900255_1.html SBI Card share price: Shares of the credit card arm of State Bank of India (SBI) tanked 6.5 per cent to Rs

Medi Assist IPO: Should You Subscribe? – The Hindu BusinessLine

https://www.thehindubusinessline.com/portfolio/stock-fundamental-analysis-india/medi-assist-ipo-should-you-subscribe/article67734147.ece Clipped from: https://www.thehindubusinessline.com/portfolio/stock-fundamental-analysis-india/medi-assist-ipo-should-you-subscribe/article67734147.ece Leading TPA player, Medi Assist, can ride industry growth from the front Medi Assist Healthcare Services or Medi Assist is the first

bank stocks outlook: PSU banks a tactical buy, makes more sense to go for ICICI, Axis, HDFC, Kotak banks: Anand Tandon – The Economic Times

Clipped from: https://economictimes.indiatimes.com/markets/expert-view/psu-banks-tactical-buy-makes-more-sense-to-go-for-icici-axis-hdfc-kotak-banks-anand-tandon/articleshow/96518860.cms SECTIONS PSU banks a tactical buy, makes more sense to go for ICICI, Axis, HDFC, Kotak banks: Anand Tandon Last Updated: Dec 26,

Stock Radar: Breakout from 5-month consolidation range could push this pharma stock beyond Rs 1,000; time to buy?

Stock Radar: Breakout from 5-month consolidation range could push this pharma stock beyond Rs 1,000; time to buy? https://economictimes.indiatimes.com/markets/stocks/news/stock-radar-breakout-from-5-month-consolidation-range-could-push-this-pharma-stock-beyond-rs-1000-time-to-buy/articleshow/94644091.cms Download Economic Times App to stay

1 2 3 5